Do you or someone in your family have Hemophilia A? If so, you probably know all too well the difficulty of stopping bleeding even from a small cut, and the need for frequent injections. This is truly a life-changing challenge. But now there is a new drug that can be used to treat this condition, and it can be used just once a week. Today, we are talking about that drug called Altuviiio.
What is Hemophilia A? How can Altuviiio help?
Simply put, hemophilia A is a genetic condition that is passed down from parent to child. A person with this condition has very low levels of Factor VIII, an important protein that helps blood clot.
Think of our blood as the mortar that holds a wall together. When a wound occurs, this mortar needs to bind together to close it. Factor VIII is like the cement that holds this mortar together. Because a person with hemophilia A lacks this 'cement' (Factor VIII), it takes a long time to stop bleeding from a wound.
The condition can be mild, moderate, or severe, depending on the level of factor VIII. Because the disease is inherited (X-linked), it is most common in males, and the most severe cases are seen in them. Women can also be affected, but symptoms are usually milder.
A person with severe hemophilia may bleed into joints, muscles, or internal organs for no apparent reason, not just from a minor cut. We call these "spontaneous bleeds." If these are not treated properly, they can cause long-term damage and even be life-threatening.
The usual treatment is to inject recombinant factor VIII protein, which is made in a laboratory. This is used in two ways:
1. "On-demand" treatment: Giving the injection only when bleeding occurs to stop it.
2. Preventive treatment: To prevent bleeding in patients with severe conditions, continuous injections are given on a set schedule (for example, two or three times a week).
This is where Altuviiio comes in. While most existing factor VIII medications require two or three doses per week, Altuviiio is a once-a-week dose. This is because its special protein structure (`Fc-VWF-XTEN`) allows the factor VIII to remain stable and active in the body for a long time.
How do you use this medicine?
Altuviiio is a liquid medicine given into a vein. That is, an IV (intravenous) infusion. This is usually given by a healthcare professional in a hospital or clinic.
However, if you prefer, you or a caregiver can be trained to give this medicine at home. You should discuss this with your doctor to decide if this is an option for you.
The medicine box contains a vial of powder, a syringe of liquid, and other necessary equipment. First, you need to mix the powder and liquid to reconstitute the medicine. To do this, you need to use a special adapter to slowly inject the liquid from the syringe into the vial. Then, you need to slowly swirl the vial to completely dissolve the powder. Next, you need to draw the liquid back into the syringe.
Most important: Look carefully before using the medicine. The prepared liquid should be clear, colorless or light yellow . Do not use it if it has any blemishes or particles. The prepared medicine should be used within 3 hours.
You may need more than one vial for your prescribed dose. If so, you will need to combine the medication from several vials into a large syringe that your doctor will give you.
Once the dose is ready, a special tube is attached to the syringe, which is connected to a needle inserted into the vein. The syringe is then slowly squeezed to inject the medicine into the body. This can take anywhere from 1 to 10 minutes.
What are the specific risks of this medicine?
Sometimes, our body makes something like 'fighters' against this externally administered Factor VIII protein. In medical terms, these are called inhibitors or antibodies. If these inhibitors are formed, they destroy Factor VIII, making the drug much less effective.
It's not yet clear how common this is among people using Altuviiio. But don't worry, your doctor will regularly check your blood to see if these inhibitors have developed.
- If the inhibitors are at low levels, the doctor may increase the dosage of the medication.
- If your inhibitor levels become too high, you may no longer be able to use Altuviiio. If this happens, your doctor will explain to you other treatments that are specifically designed for people with inhibitors.
What did the studies find?
Studies done to see the effectiveness of Altuviiio have yielded very good results. Let's look at it in a simple table.
| Study group | Key findings |
|---|---|
| Adults and young children (ages 12+) |
|
| Young children (under 12 years old) |
|
These results show that Altuviiio is a very effective drug for preventing bleeding and controlling bleeding if it occurs.
A few more things to know
- How quickly does the medicine work?
Altuviiio increases your factor VIII levels immediately after injection. This reduces the risk of bleeding quickly. However, do not stop taking the medicine without your doctor's advice . To keep your factor VIII levels high, you need to take the medicine as scheduled every week.
- Does it interact with other medications?
As far as we know, Altuviiio has not been reported to interact with other medications. However, it is important to tell your doctor about all medications you take, even vitamins.
- Is this a special medicine?
Yes. Altuviiio is a 'specialty' medicine. This means that it may not be available at a regular pharmacy, and may need to be obtained from a hospital specialty pharmacy or through a government-provided system. Your doctor will guide you on this.
Take-Home Message
- Altuviiio is a new drug used to treat hemophilia A, given intravenously just once a week.
- This helps keep Factor VIII levels high for a long time and prevents sudden bleeding.
- Studies have proven that this medicine is very effective.
- You can also take this medicine at home, following the advice of your doctor and after proper training.
- Always talk to your doctor about any problems, side effects, or other medications you are taking. Never stop taking a medication without medical advice.
💬 අදහස් (0)
තවමත් කිසිදු අදහසක් පළ කර නොමැත. ඔබේ අදහස පළමු වරට මෙහි එක් කරන්න.
ඔබේ අදහස එක් කරන්න